Rate of Contrast Extravasation on Computed Tomographic Angiography Predicts Hematoma Expansion and Mortality in Primary Intracerebral Hemorrhage

Stroke

Volumn 46, Issue 9, 2015, Pages 2498-2503

  Brouwers, H Bart ^a,b   Battey, Thomas W K ^b   Musial, Hayley H ^b   Ciura, Viesha A ^b   Falcone, Guido J ^b   Ayres, Alison M ^b   Vashkevich, Anastasia ^b   Schwab, Kristin ^b   Viswanathan, Anand ^b   Anderson, Christopher D ^b   Greenberg, Steven M ^b   Pomerantz, Stuart R ^b   Ortiz, Claudia J ^b   Goldstein, Joshua N ^b   Gonzalez, R Gilberto ^b   Rosand, Jonathan ^b   Romero, Javier M ^b  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

cerebral hemorrhage; CT angiography; intracerebral hemorrhage; mortality

Indexed keywords

WARFARIN;

AGE; AGED; ARTICLE; BRAIN HEMORRHAGE; COHORT ANALYSIS; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CONTRAST MEDIUM EXTRAVASATION; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; FEMALE; FOLLOW UP; HEMATOMA; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEUROIMAGING; PRIORITY JOURNAL; PROGNOSIS; SEX DIFFERENCE; BRAIN ANGIOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; MIDDLE AGED; PROCEDURES; RADIOGRAPHY; SINGLE BLIND PROCEDURE; VERY ELDERLY;

AGED; AGED, 80 AND OVER; CEREBRAL ANGIOGRAPHY; CEREBRAL HEMORRHAGE; COHORT STUDIES; DISEASE PROGRESSION; FEMALE; HEMATOMA; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; SINGLE-BLIND METHOD; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84940416472     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.115.009659     Document Type: Article

References (23)

1. van Asch CJ, Luitse MJ, Rinkel GJ, van der Tweel I, Algra A, Klijn CJ. Incidence, case fatality, and functional outcome of intracerebral haemorrhage over time, according to age, sex, and ethnic origin: a systematic review and meta-analysis. Lancet Neurol. 2010;9:167-176. doi: 10.1016/S1474-4422(09)70340-0.
2. Broderick JP, Brott TG, Duldner JE, Tomsick T, Huster G. Volume of intracerebral hemorrhage. A powerful and easy-to-use predictor of 30-day mortality. Stroke. 1993;24:987-993.
3. Davis SM, Broderick J, Hennerici M, Brun NC, Diringer MN, Mayer SA, et al; Recombinant Activated Factor VII Intracerebral Hemorrhage Trial Investigators. Hematoma growth is a determinant of mortality and poor outcome after intracerebral hemorrhage. Neurology. 2006;66:1175-1181. doi: 10.1212/01.wnl.0000208408.98482.99.
4. Dowlatshahi D, Demchuk AM, Flaherty ML, Ali M, Lyden PL, Smith EE; VISTA Collaboration. Defining hematoma expansion in intracerebral hemorrhage: relationship with patient outcomes. Neurology. 2011;76:1238-1244. doi: 10.1212/WNL.0b013e3182143317.
5. Delcourt C, Huang Y, Arima H, Chalmers J, Davis SM, Heeley EL, et al; INTERACT1 Investigators. Hematoma growth and outcomes in intracerebral hemorrhage: the INTERACT1 study. Neurology. 2012;79:314-319. doi: 10.1212/WNL.0b013e318260cbba.
6. Mayer SA, Brun NC, Begtrup K, Broderick J, Davis S, Diringer MN, et al; Recombinant Activated Factor VII Intracerebral Hemorrhage Trial Investigators. Recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med. 2005;352:777-785. doi: 10.1056/NEJMoa042991.
7. Mayer SA, Brun NC, Begtrup K, Broderick J, Davis S, Diringer MN, et al; FAST Trial Investigators. Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med. 2008;358:2127-2137. doi: 10.1056/NEJMoa0707534.
8. Qureshi AI, Palesch YY. Antihypertensive Treatment of Acute Cerebral Hemorrhage (ATACH) II: design, methods, and rationale. Neurocrit Care. 2011;15:559-576. doi: 10.1007/s12028-011-9538-3.
9. Anderson CS, Heeley E, Huang Y, Wang J, Stapf C, Delcourt C, et al; INTERACT2 Investigators. Rapid blood-pressure lowering in patients with acute intracerebral hemorrhage. N Engl J Med. 2013;368:2355-2365. doi: 10.1056/NEJMoa1214609.
10. Mayer SA, Davis SM, Skolnick BE, Brun NC, Begtrup K, Broderick JP, et al; FAST trial investigators. Can a subset of intracerebral hemorrhage patients benefit from hemostatic therapy with recombinant activated factor VII? Stroke. 2009;40:833-840. doi: 10.1161/STROKEAHA.108.524470.
11. Brouwers HB, Greenberg SM. Hematoma expansion following acute intracerebral hemorrhage. Cerebrovasc Dis. 2013;35:195-201. doi: 10.1159/000346599.
12. Wada R, Aviv RI, Fox AJ, Sahlas DJ, Gladstone DJ, Tomlinson G, et al. CT angiography "spot sign" predicts hematoma expansion in acute intracerebral hemorrhage. Stroke. 2007;38:1257-1262. doi: 10.1161/01. STR.0000259633.59404.f3.
13. Goldstein JN, Fazen LE, Snider R, Schwab K, Greenberg SM, Smith EE, et al. Contrast extravasation on CT angiography predicts hematoma expansion in intracerebral hemorrhage. Neurology. 2007;68:889-894. doi: 10.1212/01.wnl.0000257087.22852.21.
14. Brouwers HB, Goldstein JN, Romero JM, Rosand J. Clinical applications of the computed tomography angiography spot sign in acute intracerebral hemorrhage: a review. Stroke. 2012;43:3427-3432. doi: 10.1161/STROKEAHA.112.664003.
15. Demchuk AM, Dowlatshahi D, Rodriguez-Luna D, Molina CA, Blas YS, Dzialowski I, et al; PREDICT/SunnyBrook ICH CTA Study Group. Prediction of haematoma growth and outcome in patients with intracerebral haemorrhage using the CT-angiography spot sign (PREDICT): a prospective observational study. Lancet Neurol. 2012;11:307-314. doi: 10.1016/S1474-4422(12)70038-8.
16. Dowlatshahi D, Hogan MJ, Sharma M, Stotts G, Blacquiere D, Chakraborty S. Ongoing bleeding in acute intracerebral haemorrhage. Lancet. 2013;381:152. doi: 10.1016/S0140-6736(12)60829-0.
17. Wojcik NC, Huebner WW, Jorgensen G. Strategies for using the National Death Index and the Social Security Administration for death ascertainment in large occupational cohort mortality studies. Am J Epidemiol. 2010;172:469-477. doi: 10.1093/aje/kwq130.
18. Delgado Almandoz JE, Yoo AJ, Stone MJ, Schaefer PW, Goldstein JN, Rosand J, et al. Systematic characterization of the computed tomography angiography spot sign in primary intracerebral hemorrhage identifies patients at highest risk for hematoma expansion: the spot sign score. Stroke. 2009;40:2994-3000. doi: 10.1161/STROKEAHA.109.554667.
19. Brott T, Broderick J, Kothari R, Barsan W, Tomsick T, Sauerbeck L, et al. Early hemorrhage growth in patients with intracerebral hemorrhage. Stroke. 1997;28:1-5.
20. Huynh TJ, Keith J, Aviv RI. Histopathological characteristics of the "spot sign" in spontaneous intracerebral hemorrhage. Arch Neurol. 2012;69:1654-1655. doi: 10.1001/archneurol.2012.672.
21. Fisher CM. Pathological observations in hypertensive cerebral hemorrhage. J Neuropathol Exp Neurol. 1971;30:536-550.
22. Romero JM, Brouwers HB, Lu J, Delgado Almandoz JE, Kelly H, Heit J, et al. Prospective validation of the computed tomographic angiography spot sign score for intracerebral hemorrhage. Stroke. 2013;44:3097-3102. doi: 10.1161/STROKEAHA.113.002752.
23. Lees KR, Bluhmki E, von Kummer R, Brott TG, Toni D, Grotta JC, et al; ECASS, ATLANTIS, NINDS and EPITHET rt-PA Study Group. Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials. Lancet. 2010;375:1695-1703. doi: 10.1016/S0140-6736(10)60491-6.